The Purpose of This Study is to Determine the Safety, Tolerability, and Pharmacokinetics of Brexpiprazole Long-acting Injection Following a Single Administration in Healthy Subjects/Patients With Schizophrenia.
Clinical trial NCT06674694 · RECRUITING
Trial details
- NCT number
- NCT06674694
- Sponsor
- Sichuan Kelun Pharmaceutical Co.,Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-10
- Primary completion
- 2026-06-30
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.